Clinical Trial Update: Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Clinical trial update reporting Phase 2 results for rituximab in combination with denileukin diftitox in previously untreated stage III or IV follicular B-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• ONTAK (denileukin diftitox)
• Rituximab (rituximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-18